| Old Articles: <Older 3461-3470 Newer> |
 |
BusinessWeek February 12, 2007 Burrows & Saminather |
Precision-Guided Cancer Weapons Innovations in radiation therapy are reducing "collateral damage" and saving lives.  |
BusinessWeek February 12, 2007 Nichola Saminather |
Radiation Therapy: New Rays Of Hope More than two-thirds of all cancer patients in the U.S. receive radiation treatments as part of their hospital care. New technology could greatly improve the prognosis.  |
The Motley Fool February 5, 2007 Brian Lawler |
Gilead's Gold Mine In the fourth quarter, the pharmaceutical continues to rake in the cash from its top products. Investors, take note.  |
The Motley Fool February 5, 2007 Ryan Fuhrmann |
Boston Scientific's Unscientific Outlook There's still uncertainty as the med-tech company blends an acquisition and deals with controversy. Investors, take note.  |
Managed Care January 2007 Maureen Glabman |
Will 'Mea Culpa' Work for Health Plans Too? Hospitals and physicians, to varying degrees, are finding that doing the right thing is good business practice.  |
Managed Care January 2007 Tom Reinke |
Rise of the PHR It isn't nearly as comprehensive and trustworthy as the ideal electronic health record, but what's called the personal health record has its place.  |
Managed Care January 2007 Lola Butcher |
Employers Publish Guide on Prevention's Worth The National Business Group on Health introduces the Purchaser's Guide to Clinical Preventive Services  |
Managed Care January 2007 |
The Use of Therapeutic Interchange For Biologic Therapies The stated goal of therapeutic interchange is to achieve an improved or neutral outcome with the new agent while reducing overall treatment costs.  |
Managed Care January 2007 |
Medicare's P4P Program Under Fire Before It Has Begun Just before adjourning last month, the outgoing Congress passed legislation that would set up a pay-for-performance program in Medicare.  |
Managed Care January 2007 Martin Sipkoff |
Employers Want Plans & PBMs To Push Hard for Generics Health insurers' aggressive stand on members' use of generic drugs can attract new clients, but does it interfere with the physician-patient relationship?  |
| <Older 3461-3470 Newer> Return to current articles. |